Determination of regions important for Monoamine oxidase (MAO) A and B substrate and inhibitor selectivities

被引:0
|
作者
Shih, JC [1 ]
Chen, K [1 ]
Geha, RM [1 ]
机构
[1] Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA
来源
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT | 1998年 / 52期
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
MAO-A and -B are defined by their substrate and inhibitor preferences. To determine which regions of the isoenzymes confer these preferences, we have constructed six chimeric MAO enzymes by reciprocally exchanging corresponding N-terminal, C-terminal, and internal segments of MAO-A and -B then determined the catalytic properties of these chimeric enzymes. N-terminal chimerics A(45)B and B(36)A were made by exchanging amino acid segments 1-45 and 1-36 of MAO-A and -B respectively. C-terminal chimerics A(402)B and B(393)A were made by exchanging amino acid segments 403-527 and 394-520 of MAO-A and -B respectively, and internal chimerics AB(161-375)A and BA(152-366)B were made by exchanging amino acid segments 161-375 and 152-366 of MAO-A and -B respectively. The enzymatic properties observed for the chimerics suggest that the exchanged internal regions but not the N- or C-terminal regions confer substrate and inhibitor preferences.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [31] Computational Fragment-Based Design Facilitates Discovery of Potent and Selective Monoamine Oxidase-B (MAO-B) Inhibitor
    Jin, Chuan-Fei
    Wang, Zhi-Zheng
    Chen, Kang-Zhi
    Xu, Teng-Fei
    Hao, Ge-Fei
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 15021 - 15036
  • [32] Mechanism and kinetics of inhibition of human monoamine oxidase (MAO)-A and B by Aplysinopsin analogs
    Chaurasiya, N. D.
    Lewellyn, K.
    Zjawiony, J. K.
    Walker, L. A.
    Tekwani, B. L.
    PLANTA MEDICA, 2014, 80 (10) : 768 - 768
  • [33] PROMOTER ORGANIZATION AND ACTIVITY OF HUMAN MONOAMINE-OXIDASE (MAO) A AND B GENES
    ZHU, QS
    GRIMSBY, J
    CHEN, K
    SHIH, JC
    JOURNAL OF NEUROSCIENCE, 1992, 12 (11): : 4437 - 4446
  • [34] NEW APPROACHES TO CHARACTERIZATION OF MITOCHONDRIAL MONOAMINE-OXIDASE (MAO) TYPES A AND B
    BATHINA, HB
    HUPRIKAR, SV
    ZELLER, EA
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 293 - 293
  • [35] Personality and B platelet monoamine oxidase (MAO) activity in a sample of Spanish interns
    Bosque, J
    Planella, R
    Batalla, Y
    Torrent, A
    Nieves, M
    Pifarre, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S645 - S645
  • [36] Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity
    Bartl, Jasmin
    Mueller, Thomas
    Gruenblatt, Edna
    Gerlach, Manfred
    Riederer, Peter
    JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (04) : 379 - 383
  • [37] Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity
    Jasmin Bartl
    Thomas Müller
    Edna Grünblatt
    Manfred Gerlach
    Peter Riederer
    Journal of Neural Transmission, 2014, 121 : 379 - 383
  • [38] Linezolid is a selective inhibitor of recombinant human monoamine oxidase B and is an activator of recombinant human monoamine oxidase A
    Mankowski, DC
    DRUG METABOLISM REVIEWS, 2003, 35 : 86 - 86
  • [39] MODIFICATION OF SUBSTRATE-INHIBITOR AFFINITIES OF HUMAN-PLATELET MONOAMINE OXIDASE-B INVITRO
    SZUTOWICZ, A
    TOMASZEWICZ, M
    ORSULAK, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (30) : 17660 - 17664
  • [40] MONOAMINE OXIDASE-B (MAO-B) INHIBITOR THERAPY IN PARKINSONS-DISEASE - THE DEGREE AND REVERSIBILITY OF HUMAN BRAIN MAO-B INHIBITION BY RO 19 6327
    FOWLER, JS
    VOLKOW, ND
    LOGAN, J
    SCHLYER, DJ
    MACGREGOR, RR
    WANG, GJ
    WOLF, AP
    PAPPAS, N
    ALEXOFF, D
    SHEA, C
    GATLEY, SJ
    DORFLINGER, E
    YOO, K
    MORAWSKY, L
    FAZZINI, E
    NEUROLOGY, 1993, 43 (10) : 1984 - 1992